Variability in the fibronectin binding capacity may influence the recovery of monocytic EPCs in the culture, but there was no difference in an expression level of α1β5 integrin, a receptor for fibronectin, between circulating CD14+ monocytes from SSc patients and those from healthy individuals (data not shown). Here, CD14 is linked to systemic sclerosis.